At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 46 enrolled
Drug / intervention
7000lux broad-spectrum light +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy of Light Therapy for Bipolar Depression: A Randomized Controlled Trial
In Brief
A Phase 3 clinical trial evaluating 7000lux broad-spectrum light and 50lux dim red light for Bipolar Disorder and Major Depressive Episode. Completed, enrolled 46 participants across 2 sites.
Detailed Summary
The purpose of this study is to understand the efficacy of light therapy for bipolar depression.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBipolar Disorder, Major Depressive Episode
CountriesUnited States
CollaboratorsUniversity of Pittsburgh
Timeline
Phase 3CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 2009
Enrollment StartMay 2009
Primary CompletionDec 2014
Study CompletionFeb 2015
TodayJul 2026
First PostedFeb 27, 2009
Enrollment StartMay 1, 2009
Primary CompletionDec 1, 2014
Study CompletionFeb 1, 2015
TodayJul 2, 2026
Enrollment to primary: 5.6 yearsPosted 17.3 years ago
Interventions
7000lux broad-spectrum lightdevice
dosage - 15-60minutes NOON-2PM daily
50lux dim red lightdevice
dosage: 15-60minutes NOON-2PM daily